Genome Editing Tools represent a transformative class of technologies that enable precise modification of an organism's DNA. Among the most influential tools is CRISPR-Cas9, a revolutionary system derived from bacteria that utilizes a guide RNA to target specific DNA sequences and the Cas9 enzyme to induce precise cuts. This cut triggers cellular repair mechanisms, allowing the introduction of desired genetic alterations. Other genome editing tools include zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), which also facilitate targeted DNA modifications. These tools empower researchers to edit genes with unprecedented precision, facilitating studies on gene function, regulation, and potential therapeutic interventions for genetic disorders. While the applications are promising, ethical concerns surrounding off-target effects and unintended consequences in human germline editing necessitate rigorous oversight. The continual refinement of these tools, exploration of novel techniques, and ethical considerations will shape the future of genome editing, impacting fields ranging from medicine to agriculture and contributing to the advancement of precision genetic interventions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy